MUSA 6

Morphological Sonographic Assessment (MUSA) - 6: Translational research: liquid biopsies - MUSA 6

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON58472

Enrollment

Registered

2025-02-07

Start date

2026-03-01

Completion date

Unknown

Last updated

2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine sarcomas Malignant tumor uterus

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Uterine disorderSonographic atypical myomaMalignant Uterine sarcoma

Exclusion criteria

Exclusion criteria: < 18 yearsPregnancy

Design outcomes

Primary

Measure	Time frame
Circulating tumor-derived DNA in bloed plasma pointing to the presence of a uterine malignancy.	—

Secondary

Measure	Time frame
Serum biomarkers: VEGF (vascular endothelial growth factor), bFGF (basic fibroblast growth factor), CA 125, LDH (lactate dehydrogenase) and GDF-15 (growth differentiation factor 1 5)Isolating peripheral blood mononuclear cells (PBMC)	—

Countries

Belgium, Netherlands

Contacts

Public ContactJ.A.F. Huirne

Amsterdam UMC

gyn_benigne@amsterdamumc.nl0205669111

Outcome results